Idera Pharmaceuticals, Inc. (IDRA) Posts Narrower than Expected Q1 Loss

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q1 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Idera Pharmaceuticals, Inc. (IDRA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• JPMorgan Reiterates Overweight Rating on Marvell (MRVL)
• Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55